Fluorescence-Guided Surgery for Head and Neck Cancers

"5-Aminolevulinic acid Hydrochloride can target scalp structure, carcinoma, and squamous cell carcinoma."

"Currently, there are 20 clinical trials studying the effects of 5-Aminolevulinic acid Hydrochloride. 2 of these trials have reached Phase 3. The majority of these clinical trials originate from Lebanon and New hampshire; though, 59 different locations across the world are running studies for 5-Aminolevulinic acid Hydrochloride."

"The clinicaltrials.gov website provides evidence that this study is enrolling patients at the moment. The listing for this trial was first published on September 14th 2021 and was updated as recently as October 28th, 2021. There are 23 participants needed between 3 sites in total."

"The age range that is eligible for this particular study starts at 18 years old and goes up to 80 years old."

"Up to 23 people with skull base neoplasms who meet the age criteria of 18-80 years old may be recruited for this trial. Most notably, candidates are required to have a Karnofsky score >60%. To be eligible, potential subjects must also have documentation of a new or recurrent head and neck or skull base tumor which will require surgical resection as part of their planned treatment."

"5-Aminolevulinic acid Hydrochloride is a Phase 2 medication, so while there is some evidence of its safety, none exists for its efficacy. Our team at Power gave it a score of 2."

"That is correct. The information available on clinicaltrials.gov demonstrates that this study is still recruiting patients. This trial was originally posted on September 14th, 2021 and was updated as recently as October 28th, 2021. They are currently looking for 23 individuals across 3 different sites."